UAE allows health staff to take emergency COVID vaccine

▴ uae-allows-health-staff-take-emergency-covid-vaccine
A phase III trial of a COVID-19 inactivated vaccine developed by Chinese state-owned pharmaceutical company Sinopham began in the UAE in July and is yet to be completed.

The United Arab Emirates on Monday granted emergency approval for use of a coronavirus vaccine, six weeks after human trials in the Gulf Arab state started.

A phase III trial of a COVID-19 inactivated vaccine developed by Chinese state-owned pharmaceutical company Sinopham began in the UAE in July and is yet to be completed.

"The vaccine will be available to our first line of defense heroes who are at the highest risk of contracting the virus," said the National Emergency Crisis and Disaster Management Authority in a tweet.

The announcement comes amid a surge in new COVID-19 cases in the UAE, which reported 1,007 cases on Saturday, its highest since the start of the pandemic. There were 777 new cases on Monday.

Emergency use of the vaccine, which is still being tested, was granted after set criteria and after it had been tested on 31,000 volunteers, it said.

Mild and expected side effects occurred but there have been no severe side effects, the agency said without specifying. It added a thousand people suffering from chronic diseases who took part saw no complications.

Sinopharm secured approval for the trial in late June. The experimental vaccine passed Phases I and II of clinical trials with 100% of volunteers generating antibodies after two doses in 28 days, an Abu Dhabi government statement said in July.

According to the Centers for Disease Control, inactivated vaccines - made with either inactivated (killed) viruses or with a protein from the virus - are well known and have been used against diseases such as influenza and measles.

Russia in August become the first country in the world to grant regulatory approval to a coronavirus vaccine, after less than two months of human testing.

Tags : #UAE #Health #COVID-19 #Vaccine #Emergency

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026
Tuberculosis Contact Screening: How Preventive Care Works Around ExposureNovember 13, 2026
COPD Care in India: Linking Diagnosis, Inhaler Education and Follow-UpNovember 13, 2026
Management of ANCA Glomerulonephritis: Induction & Maintenance ProtocolsNovember 12, 2026
Smart Hospital Command Centres Transforming IndiaNovember 12, 2026
Gamma Knife Surgery in India: What You Need to KnowNovember 12, 2026